Eva Madrid, the Lead of Cochrane’s new Iberoamérica Evidence Synthesis Unit, spoke on the panel of the launch event for the ...

Dr. Barry Davies joins Mosaic Therapeutics as CSO, bringing 25 years of drug discovery expertise to advance targeted oncology therapies and precision medicine.

Significant investments in digital health, telemedicine, and Artificial Intelligence (AI)-driven diagnostics have reshaped ...

The current expectation is that every ovulatory menstrual cycle will have a luteal phase (the time from egg released until ...

Doctors have long believed the cancer drug 5-fluorouracil works by damaging the building blocks of DNA, but researchers have now found that in certain cancers, it kills cells by interfering with RNA ...

One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

Psychiatric drugs are reported to be about 50% more effective in clinical trials funded by the drug’s manufacturer than when trials of the same drug are sponsored by other groups, new research shows.

The current expectation is that every ovulatory menstrual cycle will have a luteal phase (the time from egg released until ...

Broadening global laboratory services for clinical research To serve pharma and biotech customers with advanced laboratory services and leading-edge instrumentation across all phases of pharmaceutical ...

Researchers describe the mechanisms of how alterations in the CDK12 gene drive prostate cancer development and report on a promising degrader that targets CDK12 and a related gene to destroy tumors.

In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation more ...